Effect 0f a herbal face gel on skin hydration.
- Registration Number
- CTRI/2019/03/018233
- Lead Sponsor
- Ramaiah Indic SPecialty Ayurveda
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 50
1.Male and female healthy volunteers, with age 18â??45 years
2.Subjects willing and able to provide informed consent voluntarily
3. Subjects having normal to moderate dry skin as assessed on the 4-point scale given below
4.Willing to maintain the investigational product use throughout the study.
5.Subjects who have not undergone any skin therapy (eg. De-tan, etc.) in last 3 months
6.Subjects with no known allergy to any of the test ingredients
7.Subjects who are willing to refrain from using any skin care product for the face other than the investigational product, like, moisturizers, lotions and face creams, for the duration of the study
8.Subjects willing and able to comply with all trial requirements.
9.Laboratory workup within normal limits; including complete hemogram, glucose, blood urea nitrogen, creatinine, liver function test, lipid profile, thyroid-stimulating hormone, urine pregnancy test
1.Subjects who have skin diseases like psoriasis, atopic dermatitis , severe dry, self-approved acne etc. at the time of screening
2. Subject with chronic systemic illnesses or treatment that can affect skin health eg. Dialysis
3.Subjects on oral medications or suffering from chronic illness which will compromise the study
4.Subjects who have participated in a similar investigation in the past four weeks
5.Pregnant or lactating women
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change in the moisturization of the skin will be assessed by the senior Ayurveda clinician using a 4-point scale-overall dry skin score.Timepoint: At the end of 30 days
- Secondary Outcome Measures
Name Time Method A self-perceived skin health satisfaction questionnaire will also be administered to the subjects at baseline and at the end of the study.Timepoint: at the end of 30 days